Newsfeeds - Spark Newswire

2 minute read

This Is What Whales Are Betting On Novavax

Today, 11:18 PM

Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

NVAX

1 minute read

JP Morgan Maintains Neutral on Novavax, Raises Price Target to $209

By Benzinga Newsdesk

Today, 11:18 PM

JP Morgan analyst Eric Joseph maintains Novavax (NASDAQ:NVAX) with a Neutral and raises the price target from $172 to $209.

NVAX

2 minute read

Novavax Shares Fall On Heavy Options Volume Following COVID Vaccine Approval By EU

By Chris Capre

Today, 11:18 PM

In what should have been good news for the stock, Novavax Inc (NASDAQ: NVAX) is down over 6% on the day on heavy volumes with over 10 million shares traded (double the 10 day average) and over 57,000 options traded.

NVAX

1 minute read

Novavax Shares Quiet Following Co. CEO Comment Co. Will Be Able To Produce 2B COVID-19 Vaccine Doses During Q1’22

By Benzinga Newsdesk

Today, 11:18 PM

-Reuters citing CNBC interview

NVAX

1 minute read

Novavax’s COVID-19 Vaccine Scores Conditional Approval In Europe

By Vandana Singh

Today, 11:18 PM

The European Commission has granted conditional marketing authorization to Novavax Inc's<

NVAX

3 minute read

FDA
News

Novavax Confirms Earlier Report WHO Grants Second Emergency Use Listing For Co’s COVID-19 Vaccine

By Benzinga Newsdesk

Today, 11:18 PM

Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the World Health Organization (WHO)

NVAX

2 minute read

Novavax Whale Trades Spotted

By Benzinga Insights

Today, 11:18 PM

A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 35 strange trades.

NVAX

1 minute read

Novavax To Possibly Kickstart COVID-19 Vaccine Delivery To EU In Q1 2022: Source

By Vandana Singh

Today, 11:18 PM

Novavax Inc (NASDAQ: NVAX) is expected to start delivering its COVID-19 vaccines to the European Union in Q1 of 2022,

NVAX

1 minute read

Novavax Announces European Medicines Agency Has Recommended Granting A Conditional Marketing Authorization For Novavax’ COVID-19 Vaccine

By Bill Haddad

Today, 11:18 PM

GAITHERSBURG, Md., Dec. 20, 2021 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,

NVAX

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 11:18 PM

ALLO